Glenmede Trust’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $492K | Buy |
21,763
+929
| +4% | +$20.9K | ﹤0.01% | 990 |
|
|
2026
Q1 | $470K | Sell |
20,834
-249
| -1% | -$5.72K | ﹤0.01% | 989 |
|
|
2025
Q4 | $502K | Buy |
+21,083
| New | +$524K | ﹤0.01% | 942 |
|
|
2025
Q1 | $520K | Buy |
20,864
+1,050
| +5% | +$25K | ﹤0.01% | 900 |
|
|
2024
Q4 | $449K | Buy |
19,814
+7,092
| +56% | +$154K | ﹤0.01% | 973 |
|
|
2024
Q3 | $271K | Buy |
+12,722
| New | +$250K | ﹤0.01% | 1139 |
|
|
2024
Q1 | – | Sell |
-13,806
| Closed | -$288K | – | 1359 |
|
|
2023
Q4 | $288K | Sell |
13,806
-1,636
| -11% | -$31.4K | ﹤0.01% | 1040 |
|
|
2023
Q3 | $333K | Buy |
15,442
+443
| +3% | +$10.8K | ﹤0.01% | 958 |
|
|
2023
Q2 | $319K | Hold |
14,999
| – | – | ﹤0.01% | 966 |
|
|
2023
Q1 | $319K | Buy |
14,999
+2,340
| +18% | +$44.8K | ﹤0.01% | 971 |
|
|
2022
Q4 | $207K | Buy |
12,659
+556
| +5% | +$8.24K | ﹤0.01% | 1091 |
|
|
2022
Q3 | $169K | Buy |
+12,103
| New | +$229K | ﹤0.01% | 1106 |
|
|
2021
Q1 | – | Sell |
-17,450
| Closed | -$724K | – | 1215 |
|
|
2020
Q4 | $724K | Buy |
17,450
+6,189
| +55% | +$258K | ﹤0.01% | 750 |
|
|
2020
Q3 | $477K | Buy |
11,261
+9,071
| +414% | +$391K | ﹤0.01% | 799 |
|
|
2020
Q2 | $94K | Sell |
2,190
-3,519
| -62% | -$139K | ﹤0.01% | 1168 |
|
|
2020
Q1 | $209K | Hold |
5,709
| – | – | ﹤0.01% | 1184 |
|
|
2019
Q4 | $209K | Sell |
5,709
-3,699
| -39% | -$131K | ﹤0.01% | 1184 |
|
|
2019
Q3 | $315K | Sell |
9,408
-404
| -4% | -$14.3K | ﹤0.01% | 1012 |
|
|
2019
Q2 | $384K | Buy |
9,812
+745
| +8% | +$29.5K | ﹤0.01% | 976 |
|
|
2019
Q1 | $367K | Buy |
9,067
+4,161
| +85% | +$155K | ﹤0.01% | 974 |
|
|
2018
Q4 | $158K | Buy |
+4,906
| New | +$198K | ﹤0.01% | 1196 |
|
|
2018
Q2 | – | Sell |
-398
| Closed | -$20K | – | 2051 |
|
|
2018
Q1 | $20K | Hold |
398
| – | – | ﹤0.01% | 1955 |
|
|
2017
Q4 | $20K | Hold |
398
| – | – | ﹤0.01% | 1955 |
|
|
2017
Q3 | $19K | Hold |
398
| – | – | ﹤0.01% | 1986 |
|
|
2017
Q2 | $16K | Hold |
398
| – | – | ﹤0.01% | 1989 |
|
|
2017
Q1 | $16K | Sell |
398
-2,554
| -87% | -$106K | ﹤0.01% | 1989 |
|
|
2016
Q4 | $124K | Buy |
2,952
+793
| +37% | +$32.4K | ﹤0.01% | 1343 |
|
|
2016
Q3 | $93K | Sell |
2,159
-63
| -3% | -$2.82K | ﹤0.01% | 1420 |
|
|
2016
Q2 | $96K | Buy |
2,222
+939
| +73% | +$40.5K | ﹤0.01% | 1371 |
|
|
2016
Q1 | $55K | Sell |
1,283
-410
| -24% | -$17.4K | ﹤0.01% | 1491 |
|
|
2015
Q4 | $70K | Buy |
1,693
+1,173
| +226% | +$49.4K | ﹤0.01% | 1462 |
|
|
2015
Q3 | $20K | Sell |
520
-9,283
| -95% | -$378K | ﹤0.01% | 1899 |
|
|
2015
Q2 | $407K | Sell |
9,803
-394
| -4% | -$16.8K | ﹤0.01% | 1033 |
|
|
2015
Q1 | $422K | Sell |
10,197
-3,210
| -24% | -$124K | ﹤0.01% | 1022 |
|
|
2014
Q4 | $497K | Sell |
13,407
-4,678
| -26% | -$169K | ﹤0.01% | 960 |
|
|
2014
Q3 | $626K | Sell |
18,085
-21,425
| -54% | -$739K | 0.01% | 807 |
|
|
2014
Q2 | $1.32M | Sell |
39,510
-2,171
| -5% | -$72.4K | 0.01% | 632 |
|
|
2014
Q1 | $1.45M | Buy |
41,681
+4,303
| +12% | +$151K | 0.01% | 609 |
|
|
2013
Q4 | $1.33M | Sell |
37,378
-10,251
| -22% | -$344K | 0.01% | 609 |
|
|
2013
Q3 | $1.54M | Sell |
47,629
-164
| -0.3% | -$5.34K | 0.02% | 575 |
|
|
2013
Q2 | $1.69M | Buy |
+47,793
| New | +$1.66M | 0.02% | 533 |
|
Other funds holding FMS
FMI
BIP
TAM
TRSOTSOK
Glenmede Trust's FMS Position: Q2 2026 in Review
Glenmede Trust increased its Fresenius Medical Care (FMS) stake by 4.5% in Q2 2026, buying an estimated $20.9K and bringing the position to 21,763 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #990.
Glenmede Trust first reported a position in FMS in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.69M in Q2 2013. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.
- Glenmede Trust held 21,763 shares of Fresenius Medical Care worth $492K as of Q2 2026.
- Glenmede Trust bought 929 Fresenius Medical Care shares in Q2 2026, an estimated $20.9K.
- Fresenius Medical Care made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #990 holding.
- Glenmede Trust first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 41 quarters since.
- Glenmede Trust's Fresenius Medical Care position peaked at $1.69M in Q2 2013.
- 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.